Neutrophil/lymphocyte ratio in patients with atrial septal aneurysm

Figures & data

Table 1 Comparison of clinical and echocardiographic features of atrial septal aneurysm patients and controls

	Patients (N = 40)	Controls (N = 30)	P-value
Age (years)	54.4 ± 16.3	49.8 ± 11.2	NS
Male/female (n/n)	15/25	12/18	NS
LA diameter (mm)	33.5 ± 3.4	34.2 ± 3.6	NS
LVEDD (mm)	43.1 ± 4.1	44.2 ± 4.9	NS
LVESD (mm)	22.6 ± 2.7	24.4 ± 2.2	NS
RA diameter (mm)	33.5 ± 3.3	32.8 ± 3.1	NS
LVEF (%)	64.2 ± 5.2	64.8 ± 5.3	NS
BSA (m^2)	1.9 ± 0.5	1.8 ± 0.3	NS
SPAP (mmHg)	28.5 ± 3.8	25.4 ± 3.4	NS
SBP (mmHg)	121 ± 23	122.5 ± 25	NS
DBP (mmHg)	74.2 ± 11	80.3 ± 12	NS
BMI (kg/m^2)	25 ± 3.5	23 ± 3.1	NS
Smoking (n)	10	11	NS

Abbreviations: BMI, body mass index; BSA, body surface area; DBP, diastolic blood pressure; LA, left atrium; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; RA, right atrium; SBP, systolic blood pressure; SPAP, systolic pulmonary artery pressure.

Table 2 Comparison of biochemical parameters of atrial septal aneurysm patients and controls

	Patients (N = 40)	Controls (N = 30)	P-value
Glucose (mg/dL)	97.1 ± 13.9	93.3 ± 13.0	NS
Creatinine (mg/dL)	0.7 ± 0.2	0.8 ± 0.3	NS
Total cholesterol (mg/dL)	195.9 ± 52	199.2 ± 56	NS
Triglyceride (mg/dL)	124 ± 26	125 ± 29	NS
Low-density lipoprotein Cholesterol (mg/dL)	125.3 ± 9.5	133.7 ± 15	NS
High-density lipoprotein cholesterol (mg/dL)	45.8 ± 9.5	44.9 ± 8.6	NS
Hemoglobin (g/dL)	14.2 ± 2.5	14.3 ± 2.6	NS
Platelet count (×10³)	248.5 ± 62.1	282.3 ± 79.2	NS
Leukocytes, mm^3	8832 ± 2238	8225 ± 2116	NS
Neutrophils, mm^3	6318 ± 2425	4686 ± 1311	<0.001
Lymphocytes, mm^3	1862 ± 625	2911 ± 837	<0.001
Monocytes, mm^3	586 ± 142	458 ± 124	NS
Neutrophil/lymphocyte ratio	3.4 ± 1.5	1.6 ± 0.97	<0.001